In LTRs, GlycA was related to age, BMI, lipid-lowering and glucose-lowering drugs, antihypertensives, metabolic dysfunction-associated steatotic liver disease (MASLD), use of mycophenolate, prednisone, sirolimus, tacrolimus (inverse), azathioprine (inverse), total cholesterol, LDL cholesterol, triglycerides, alanine aminotransferase (ALT), aspartate aminotransferase (AST), GGT, ALP, fasting glucose, glycated hemoglobin (HbA1c), and hs-CRP in univariable analysis. The gene discussed is MAP3K14; the disease is liver disorder.